Compare Across Protocol (ACX) vs Immunefi (IMU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Across Protocol vs Immunefi — how do they compare? Across Protocol trades at Rp744.75 (market cap Rp527,52M, Rp28,21M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Across Protocol is far larger — about 19.5× Immunefi's market cap, and Across Protocol 's circulating supply is 704,7M / 1B ACX (71%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 54 Days and Immunefi for 5 Days on average.
| ACX | IMU | |
|---|---|---|
Market Cap | Rp527,52M | Rp27,03M |
Volume (24h) | Rp28,21M | Rp39,91M |
Circulating Supply | 704,7M / 1B ACX (71%) | 873,4M / 10B IMU (9%) |
Typical Hold Time | 54 Days | 5 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Across Protocol (ACX) is trading at Rp741.83 with a bearish technical signal, showing sell pressure from moving averages while oscillators remain neutral. The token is currently testing support near Rp731 with resistance at Rp756. With 71% of the 1 million max supply in circulation and an average hold time of 54 days, the token shows moderate distribution stability despite current bearish momentum.
The overall outlook remains cautious due to strong bearish technical indicators, though neutral oscillators suggest potential stabilization. Key opportunities include protocol utility in cross-chain bridging, while major risks involve low liquidity (Rp522.31M market cap) and crypto market volatility. Investors should monitor support levels for potential entry points.
Immunefi token shows limited market activity with a modest market cap of Rp27,03M and low circulation rate of 9%. The asset demonstrates minimal trading volume and network engagement, with token holders maintaining short 5-day holding periods. Recent coverage appears misaligned with the cryptocurrency's actual blockchain metrics, suggesting potential entity confusion.
Outlook remains cautious due to low liquidity and limited ecosystem development. Key opportunities include potential network growth, while major risks involve low adoption, regulatory uncertainty, and market volatility. Investors should monitor on-chain metrics for signs of genuine protocol activity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Across Protocol
Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.
Read more on ACX →About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →
